Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    New user? Click here to register. Have you forgotten your password?
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Narullevi, Hadis"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Uji Aktivitas Antimikrobial Dan Toksisitas Fraksi Etilasetat Dari Daun Tumbuhan Tabemaemantana sphaerocarpa Bl (Apocynaceae)
    (2015-07-03) Narullevi, Hadis
    The species of Tabemaemontana sphaerocarpa Bl member of Apocynaceae family, have been traditionally implemented in the treatment of antimalarial, bactericide, scabies medicine, ulcer, and strained (Eryanti et all., 2004). In vitro studies in this work presented some of the compounds such as terpenoid, alkaloid, and fenoiik. In 2005, Andrade et all., had been isolation of Tabemaemontana australis that included indole alkaloid as coronaridine(l), voacangine(2), voacangine hiroxyindolenine(3), rapicoline(4), ibogamine(5), ibogaine(6), ibogaline(7), and decetil-voacangine(8) and reported as anti inflamamoiy, anti-malarial, anti-HIV, and anti-cancer compounds. This study directs the attention to the antifungal, antibacterial, and anticancer from etilasetat fraction of Tabemaemontana sphaerocarpa Bl

DSpace software copyright © 2002-2025 LYRASIS

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback